Similar Items: Segmental fructose handling may refine the temporal glucagon‐like peptide‐1–glucagon‐like peptide‐2 framework during chronic fructose exposure
- Glucagon-Like Peptide-1 Receptor Agonists: Their Potential Role in Prediabetes
- Mirtazapine for gastrointestinal side effects of glucagon-like peptide-1 receptor agonist therapy in older adults
- Hair Loss in Patients on Glucagon-Like Peptide 1 Receptor Agonists: Understanding Risks and Managing Outcomes
- Endogenous Glucagon-Like Peptide-1 as a Potential Mediator of the Resolution of Diabetic Kidney Disease following Roux en Y Gastric Bypass: Evidence and Perspectives
- Integrated Evidence from VigiBase and Clinical Trials: A Comprehensive Pharmacovigilance Analysis of Seven Glucagon-Like Peptide 1 Receptor Agonists (GLP-1 RAs)
- Aspects of structure-activity relationships and physiology of gastrin and related peptides